|
35
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI · commercialization
|
biomedical clinical
cybersecurity
ai data science
|
— |
2026-07-10 |
2026-09-21 |
15 |
|
25
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI · commercialization
|
biomedical clinical
public health
ai data science
|
— |
2026-07-24 |
2026-09-21 |
15 |
|
17
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI · commercialization
|
biomedical clinical
public health
computing communications
|
— |
2026-07-10 |
2026-09-21 |
15 |
|
15
|
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
75A50126R00001_RFP_NPIVS_27 · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA · commercialization
|
public health
biomedical clinical
emergency disaster resilience
|
— |
2026-08-17 |
2026-10-30 |
54 |